Skip to main content
. Author manuscript; available in PMC: 2021 Mar 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2020 Oct 23;86(6):815–827. doi: 10.1007/s00280-020-04176-z

Fig. 1.

Fig. 1

HSP70 expression in patient-derived plasma and peripheral blood mononuclear cells (PBMCs). Peripheral blood samples were collected at baseline, 2–4 h after completion of onalespib on C0D4, and 2–4 h after completion of the combination of onalespib + AT7519 on C1D11, and separated into plasma and PBMC pellets. The level of soluble HSP70 protein expression was measured by ELISA in plasma (Panel a); HSP70 protein expression was measured by western blot in PBMCs and quantitated (Panel b) as reported previously [26]